OP0076 LONG-TERM OUTCOMES OF REPEAT CYCLES OF RITUXIMAB FOR SYSTEMIC MANIFESTATIONS OF SJOGREN'S DISEASE: MULTICENTRE UK COHORT STUDY (2024)
Attributed to:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2024-eular.6291
Publication URI: http://dx.doi.org/10.1136/annrheumdis-2024-eular.6291
Type: Journal Article/Review
Parent Publication: Annals of the Rheumatic Diseases